✦ LIBER ✦

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study

✍ Scribed by Adriano M. Pellicelli; Giuseppe Barbaro; Ruggiero Francavilla; Mario Romano; Giorgio Barbarini; Ettore Mazzoni; Fabrizio Mecenate; Amerigo Paffetti; Angelo Barlattani; Carlo Struglia; Roberto Villani; Leone Nauri; Lorenzo Nosotti; Orlando Armignacco; Fabrizio Ferri; Maria Pia Camporiondo; Fabrizio Soccorsi

Book ID: 116372132
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 536 KB
Volume: 30
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2008.02.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

481 Entecavir (ETV) is superior to lamiv

481 Entecavir (ETV) is superior to lamivudine and adefovir in trials of HBeAg-positive and -negative chronic hepatitis B infection: A cross-study analysis with published reports

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

734 EFFICACY OF COMBINATION THERAPY OF A

734 EFFICACY OF COMBINATION THERAPY OF ADEFOVIR AND TELBIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH A PARTIAL VIROLOGICAL RESPONSE TO ADEFOVIR MONOTHERAPY: A 48-WEEK, OPEN-LABEL, PROSPECTIVE, SINGLE CENTER STUDY

✍ X. Li; G. Lin; Y. Wu; L. Yang; X. Zhang; C. Lu; Z. Gao; Y. Chong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB